Dr. Himanshi Yaduvanshi is a PhD-trained life sciences researcher with strong expertise in oncology, immunology, and metabolic disorders, specializing in the interplay between glucose and lipid metabolism and cancer progression. Her research contributions span mechanistic studies in melanoma, breast cancer, and colon cancer, with a particular focus on metabolic reprogramming, macrophage phenotypic switching in obesity-linked tumor growth, and therapeutic modulation of cholesterol pathways. She has published several peer-reviewed research articles in respected journals such as Cancer Research, Cancer Metabolism, Molecular Cell Research, and Journal of Biosciences, in addition to contributing to preprints and collaborative manuscripts currently in preparation. Her work is further strengthened by involvement in an Indian patent on a novel anticancer therapeutic combination, demonstrating her commitment to translational innovation. Dr. Yaduvanshi’s technical proficiency encompasses flow cytometry, confocal microscopy, in vivo tumor models, metabolic assays using Seahorse technology, immunophenotyping, molecular cloning, qPCR, immunoblotting, and proteomics workflows. Her research background is distinguished by effective collaboration across multidisciplinary teams at the National Centre for Cell Science (NCCS), where she led experimental design, troubleshooting, and data analysis for complex, multi-lab projects. She has participated in national and international scientific platforms, presenting her work at the International Union of Immunological Societies (IUIS) Conference, CMBC Conference, and Immuno-Oncology Society of India (I-OSI), earning recognition for both poster and oral presentations. Beyond academic research, Dr. Yaduvanshi contributes to scientific communication and industry engagement through her roles as Technical Sales Manager at Bio Bench Solutions and Associate Editor with Springer Nature, where she ensures the quality and integrity of scientific protocols. Her work collectively supports societal impact by advancing understanding of cancer metabolism and informing the development of more effective therapeutic strategies. With a strong record of research excellence, innovation, and interdisciplinary collaboration, Dr. Yaduvanshi continues to contribute meaningfully to global biomedical science.